Navigation Links
China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
Date:4/27/2009

cipally engaged in the research, development, production and manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.

Safe Harbor Statement

This release may contain certain "forward-looking statements" relating to the business of China Biologic Products, Inc. and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements," including statements regarding: the significance of the human immunoglobulin product order to be shipped to India and its impact on the Company's own brand recognition in international markets; the ability of the Company to achieve its commercial objectives, including obtaining permission to sell Company products under its own brand in other countries; the business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and av
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Medical Technologies Receives SFDA Approval for Its Bladder Cancer FISH Probe
2. China Sky One Medical, Inc. Obtains SFDA Approvals for Geranium Ointment and Musk Liniment for Pain Relief
3. China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results
4. China Breaks Ground on Largest Comprehensive Stem Cell Storage and Processing Facility
5. China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed
6. HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China
7. China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
8. China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results
9. China Sky One Medical, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Results
10. NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStems VSEL Technology and Advancement of Medical Tourism Initiatives
11. China Sky One Medical, Inc. Provides Update on Filing Form 10-K
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)...  Having the right people at the table for ... growth and achieving clinical and operational goals. The 22 ... July 20-22, 2014, in San Diego ... healthcare experts discussing how partnerships have positively impacted their ... Chief Executive Officer of Cape Regional Medical Center located ...
(Date:7/23/2014)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... announced that the underwriters of its common stock ... an additional 420,000 shares of common stock at ... less underwriting discounts and commissions, in connection with ... shares of common stock, bringing the expected net ...
(Date:7/23/2014)... 2014 China Cord Blood Corporation (NYSE: CO ... provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, ... multi-product healthcare company catering to the mother and child segment, today ... across the PRC, Singapore , Hong ... , the Philippines and ...
(Date:7/23/2014)... Astra Nova Training , ... and pharma training services, and the Alliance ... a non-profit integrating the expertise and investments of ... global system for clinical trials, are pleased to ... expertise of industry professionals through improved and easily ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 2China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 4Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3
... , T.J. Higley and Roy Eksteen, ... , Introduction: ... many variables are examined to ensure method , ... are required to be consistent by ...
... , , ... Tosoh has introduced two new columns , with differing surface ... selectivities for a wide range of sample types. , , ... In recent years, many new octadecylsilane (ODS) chemistries have been , ...
... Authors: T.J. Higley, Tosoh Bioscience LLC, Tatsunari Yoshida, Tosoh , ... , The TSKgel Amide-80 column provides excellent selectivity ... polar carbamoyl , functionalities bonded to a silica base material. ... Introduction: , The separation of peptides with many ...
Cached Biology Technology:Mobile Phase Optimization for the Analysis of an Antibody-Based Fusion Protein and Aggregates using a TSKgel Super SW3000 Size-Exclusion Column 2Mobile Phase Optimization for the Analysis of an Antibody-Based Fusion Protein and Aggregates using a TSKgel Super SW3000 Size-Exclusion Column 3TSKgel ODS-100Z and TSKgel ODS-100V column series provides a universal solution for the analysis of samples containing acidic, basic, polar & non-polar compounds 2TSKgel ODS-100Z and TSKgel ODS-100V column series provides a universal solution for the analysis of samples containing acidic, basic, polar & non-polar compounds 3Separation of Peptides by Hydrophilic Interaction Chromatography Using TSKgel Amide-80 2Separation of Peptides by Hydrophilic Interaction Chromatography Using TSKgel Amide-80 3Separation of Peptides by Hydrophilic Interaction Chromatography Using TSKgel Amide-80 4
(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead bodies ... time of death, referred to as the post mortem ... C. megacephala from Tamil Nadu is provided for ... characterization through generation of DNA barcoding. This study, significant ... Biodiversity Data Journal . , Chrysomya megacephala ...
(Date:7/23/2014)... around the world by 2050, according to one of ... Change (IPCC), may be advantageous to the physiology and ... of forage plants such as Stylosanthes capitata Vogel ... countries such as Brazil., The conclusion is from a ... Biology at the Ribeiro Preto Faculty of Philosophy, Sciences ...
(Date:7/23/2014)... of 2015, Springer will publish the International Journal ... journal of the Taiwan Fuzzy Systems Association (TFSA). The ... visibility in the area of fuzzy research., The ... presenting high-quality papers that deal with the theory, design ... systems and extension theory systems ranging from hardware to ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 3An increase in temperature by 2050 may be advantageous to the growth of forage plants 4
... your baby isn,t destined to a life of obesity after ... The FASEB Journal . In the report, ... during pregnancy to a moderate level is enough to benefit ... that a protein called "SIRT1" rewrites a developing fetus, histone ...
... of emission reduction measures are considerable. In order ... to develop uniform assessment methods for ensuring that ... practice., Significant mitigation of climate change is widely ... considerable reductions in global greenhouse gas emissions in ...
... product secreted by a soil bacterium shows promise as ... a new study published in EMBO Molecular Medicine ... shown how pyridomycin, a natural antibiotic produced by the ... candidate is active against many of the drug-resistant types ...
Cached Biology News:Eating well during pregnancy reduces baby's obesity risk regardless of mom's size 2Effectiveness and impact of climate change mitigation measures unclear 2Effectiveness and impact of climate change mitigation measures unclear 3Scientists reveal how natural antibiotic kills tuberculosis bacterium 2
Anti-gp340 Monoclonal Antibody Description: 100 g Research Focus: cancer & cell proliferation Storage: -20C Shipping Temperature: 4C...
Sheep polyclonal to Methaqualone ( Abpromise for all tested applications). Antigen: Methaqualone(5') conjugated to BSA...
Prostaglandin-E2 receptor EP2/EP3 Market Segment: GPCRs...
Rabbit polyclonal to Testosterone 19 ( Abpromise for all tested applications). Antigen: Testosterone 19 CME HSA (Human)...
Biology Products: